Literature DB >> 10801162

Choice of hormonal therapy for prostate cancer.

D M Reese1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10801162     DOI： 10.1016/S0140-6736(00)02155-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

Review 1.  Bicalutamide: in early-stage prostate cancer.

Authors:  Christopher I Carswell; David P Figgitt
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Tissue-selective therapy of cancer.

Authors:  M V Blagosklonny
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.